Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
Sieta T de VriesMaartje J M van der SarAnna Marie ColemanYvette EscuderoAlfonso Rodríguez PascualMiguel-Ángel Maciá MartínezAmelia CupelliIlaria BaldelliIvana ŠipićAdriana AndrićLine MichanPetra DenigPeter G M Molnull nullPublished in: Drug safety (2018)
GPs, cardiologists, and pharmacists were to a similar extent (highly) familiar with DHPCs, but they differed in awareness levels of specific safety issues. Cardiologists were less aware of safety issues associated with non-cardiology drugs even if these had cardiovascular safety concerns. This implies that additional strategies may be needed to reach specialists when communicating safety issues regarding drugs outside their therapeutic area but with risks related to their field of specialisation. DHPCs were an important source for the different professions to become aware of specific safety issues, but other sources were also often used. NCAs should consider the use of a range of sources when communicating important safety issues to HCPs.